Warning
Merck Sharp & Dohme LLC Recalls Merck Emend (aprepitant) for oral suspension
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0241-2026Drug / Pharmaceutical
Merck Sharp & Dohme LLC Recalls Merck Emend (aprepitant) for oral suspension
Merck Sharp & Dohme LLC · Class II — Moderate Risk
Product Description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Reason for Recall
Presence of particulate matter: potential presence of metal particulates in the product.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
Sources: FDA openFDA Enforcement Database